Immunohistochemical study ofneu protein overexpression in clinging in situ duct carcinoma of the breast
- 1 September 1993
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 422 (5) , 375-380
- https://doi.org/10.1007/bf01605456
Abstract
The expression ofneu protein in 26 cases of clinging carcinoma (CC) of the breast was investigated. A distinction is made between two types of CC: one with pleomorphic nuclei (PN) and the other with monomorphic nuclei (MN). The PN type of CC overexpresses theneu protein in almost all cases (85.7%), its cells generally exhibit abundant cytoplasm and intraluminal necrosis is frequently observed. The MN type of CC does not overexpress theneu protein, exhibits bland cytological features and shows no necrosis. It is suggested that CC with PN is related to comedo-type carcinoma, while CC with MN is the forerunner of cribriform carcinoma in situ.Keywords
This publication has 7 references indexed in Scilit:
- Progress in molecular biology of breast cancerEuropean Journal Of Cancer, 1992
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- The subcellular localization of the neu protein in human normal and neoplastic cellsInternational Journal of Cancer, 1989
- The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissuesHistopathology, 1989
- c-erbB-2 expression in benign and malignant breast diseaseBritish Journal of Cancer, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985